Devrim Çabuk

12PUBLICATIONS

102CO-AUTHORS

Molecular targetsLiquid biopsiesPredictive and prognostic markersInnate immunityVision science

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 25, 2026

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

|May 08, 2026

Comparison of flat-dose versus weight-based dose nivolumab treatment in NSCLC patients.

|Apr 14, 2026

Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Mar 28, 2026

EASIX Score as an Independent Prognostic Marker in De Novo Metastatic Pancreatic Cancer.

İlkay Çıtakkul, Yasemin Bakkal Temi, Zehra Aytin

|Mar 14, 2026

The Pretreatment Glucose-to-Lymphocyte Ratio as an Independent Prognostic Biomarker in Ovarian Cancer.

Ece Baydar, Yasemin Bakkal Temi, İlkay Çıtakkul

|Feb 21, 2026

The prognostic significance of early changes in the lung immune prognostic index in patients treated with immunotherapy for advanced-stage lung cancer.

Muhammet Cengiz, Oktay Bozkurt, Ayşe Nuransoy Cengiz

Pageof 2

Frequent Collaborators

Elif Sahin

Umut Kefeli

Nargiz Majidova

Deniz Can Guven

Duygu Bayir

Kazım Uygun

Emel Mutlu Ozkan

Yasemin Bakkal Temi

Cengiz Akosman

Sedat Yıldırım

Frequent Collaborators

Elif Sahin

Umut Kefeli

Nargiz Majidova

Deniz Can Guven